Katie:
Duloxetine is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) similar in function to venlafaxine. It is indicated for major depressive disorders, and for diabetic peripheral neuropathic pain. New data suggest that the milk/plasma ratio is low, and the RID is low as well. The Relative infant dose is about 1.1% of the maternal dose, or less. This is too low to have clinical effects on an infant.
Vyvanse is a prodrug of dextroamphetamine. We have several studies in breastfeeding mothers suggesting that about 1.8% - 6.2% of the maternal dose transfers to the infant. Thus far, we don't have any reported complications in an infant when the proper dose is administered. However, observer for Nervousness, insomnia, anorexia, hyperexcitability.
Tom Hale Ph.D.
Announcement
Collapse
No announcement yet.
Vyvanse and cymbalta
Collapse
X
Leave a comment: